The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Design of a Broad-Range Bacteriophage Cocktail That Reduces Pseudomonas aeruginosa Biofilms and Treats Acute Infections in Two Animal Models
Open accessAbstract
The alarming diffusion of multidrug-resistant (MDR) bacterial strains requires investigations on nonantibiotic therapies. Among such therapies, the use of bacteriophages (phages) as antimicrobial agents, namely, phage therapy, is a promising treatment strategy supported by the findings of recent successful compassionate treatments in Europe and the United States. In this work, we combined host range and genomic information to design a 6-phage cocktail killing several clinical strains of Pseudomonas aeruginosa, including those collected from Italian cystic fibrosis (CF) patients, and analyzed the cocktail performance. We demonstrated that the cocktail composed of four novel phages (PYO2, DEV, E215 and E217) and two previously characterized phages (PAK_P1 and PAK_P4) was able to lyse P. aeruginosa both in planktonic liquid cultures and in biofilms. In addition, we showed that the phage cocktail could cure acute respiratory infection in mice and treat bacteremia in wax moth (Galleria mellonella) larvae. Furthermore, administration of the cocktail to larvae prior to bacterial infection provided prophylaxis. In this regard, the efficiency of the phage cocktail was found to be unaffected by the MDR or mucoid phenotype of the pseudomonal strain. The cocktail was found to be superior to the individual phages in destroying biofilms and providing a faster treatment in mice. We also found the Galleria larva model to be cost-effective for testing the susceptibility of clinical strains to phages, suggesting that it could be implemented in the frame of developing personalized phage therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing
Bankevich, A., Nurk, S., Antipov, D., Gurevich, A. A., Dvorkin, M., Kulikov, A. S., Lesin, V. M., Nikolenko, S. I., Pham, S., Prjibelski, A. D., et al. (2012) · Journal of Computational Biology · doi:10.1089/cmb.2012.0021 · Cited by 25,987
Bacteriophage resistance mechanisms
Labrie, S. J., Samson, J. E., & Moineau, S. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2315 · Cited by 2,397
The Comprehensive Antibiotic Resistance Database
McArthur, A. G., Waglechner, N., Nizam, F., Yan, A., Azad, M. A., Baylay, A. J., Bhullar, K., Canova, M. J., De Pascale, G., Ejim, L., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00419-13 · Cited by 2,226
VFDB: a reference database for bacterial virulence factors
Chen, L. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki008 · Cited by 2,097
Adams, M. H. (1959) · Interscience Publishers eBooks · doi:10.5962/bhl.title.6966 · Cited by 2,097
Schooley, R. T., Biswas, B., Gill, J. J., Hernandez-Morales, A., Lancaster, J., Lessor, L., Barr, J. J., Reed, S. L., Rohwer, F., Benler, S., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00954-17 · Cited by 1,254
Phage therapy: An alternative to antibiotics in the age of multi-drug resistance
Lin, D. M., Koskella, B., & Lin, H. C. (2017) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v8.i3.162 · Cited by 1,135
Pros and cons of phage therapy
Loc-Carrillo, C., & Abedon, S. T. (2011) · Bacteriophage · doi:10.4161/bact.1.2.14590 · Cited by 1,020
Phage treatment of human infections
Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011) · Bacteriophage · doi:10.4161/bact.1.2.15845 · Cited by 980
Phage Cocktails and the Future of Phage Therapy
Chan, B. K., Abedon, S. T., & Loc-Carrillo, C. (2013) · Future Microbiology · doi:10.2217/fmb.13.47 · Cited by 914
Chromosomal genetics of Pseudomonas
Holloway, B. W., Krishnapillai, V., & Morgan, A. F. (1979) · Microbiological Reviews · doi:10.1128/mmbr.43.1.73-102.1979 · Cited by 761
Human Volunteers Receiving Escherichia coli Phage T4 Orally: a Safety Test of Phage Therapy
Bruttin, A., & Brüssow, H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2874-2878.2005 · Cited by 563
Phage-Host Interaction: an Ecological Perspective
Chibani-Chennoufi, S., Bruttin, A., Dillmann, M.-L., & Brüssow, H. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.12.3677-3686.2004 · Cited by 511
Roach, D. R., Leung, C. Y., Henry, M., Morello, E., Singh, D., Di Santo, J. P., Weitz, J. S., & Debarbieux, L. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.06.018 · Cited by 484
Self-citationPhage Choice, Isolation, and Preparation for Phage Therapy
Gill, J., & Hyman, P. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725311 · Cited by 441
Bacteriophage Receptors, Mechanisms of Phage Adsorption and Penetration into Host Cell
RAKHUBA, D. V., KOLOMIETS, E. I., DEY, E. S., & NOVIK, G. I. (2010) · Polish Journal of Microbiology · doi:10.33073/pjm-2010-023 · Cited by 419
Optimisation of Bioluminescent Reporters for Use with Mycobacteria
Andreu, N., Zelmer, A., Fletcher, T., Elkington, P. T., Ward, T. H., Ripoll, J., Parish, T., Bancroft, G. J., Schaible, U., Robertson, B. D., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010777 · Cited by 354
ACLAME: A CLAssification of Mobile genetic Elements, update 2010
Leplae, R., Lima-Mendez, G., & Toussaint, A. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp938 · Cited by 319
Bacteriophages Can Treat and Prevent Pseudomonas aeruginosa Lung Infections
Debarbieux, L., Leduc, D., Maura, D., Morello, E., Criscuolo, A., Grossi, O., Balloy, V., & Touqui, L. (2010) · The Journal of Infectious Diseases · doi:10.1086/651135 · Cited by 304
Self-citationThe Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?
Pirnay, J.-P., De Vos, D., Verbeken, G., Merabishvili, M., Chanishvili, N., Vaneechoutte, M., Zizi, M., Laire, G., Lavigne, R., Huys, I., et al. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0313-5 · Cited by 298
Self-citationJennes, S., Merabishvili, M., Soentjens, P., Pang, K. W., Rose, T., Keersebilck, E., Soete, O., François, P.-M., Teodorescu, S., Verween, G., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1709-y · Cited by 248
Alemayehu, D., Casey, P. G., McAuliffe, O., Guinane, C. M., Martin, J. G., Shanahan, F., Coffey, A., Ross, R. P., & Hill, C. (2012) · mBio · doi:10.1128/mbio.00029-12 · Cited by 231
Role of Iron Uptake Systems in Pseudomonas aeruginosa Virulence and Airway Infection
Minandri, F., Imperi, F., Frangipani, E., Bonchi, C., Visaggio, D., Facchini, M., Pasquali, P., Bragonzi, A., & Visca, P. (2016) · Infection and Immunity · doi:10.1128/iai.00098-16 · Cited by 228
service, P. (2007) · Research in Microbiology · doi:10.1016/j.resmic.2007.07.005 · Cited by 201
Hall, A. R., De Vos, D., Friman, V.-P., Pirnay, J.-P., & Buckling, A. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.00757-12 · Cited by 180
Head, N. E., & Yu, H. D. (2003) · Infection and Immunity · doi:10.1128/iai.72.1.133-144.2004 · Cited by 178
Adapting Drug Approval Pathways for Bacteriophage-Based Therapeutics
Cooper, C. J., Khan Mirzaei, M., & Nilsson, A. S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01209 · Cited by 165
Cao, F., Wang, X., Wang, L., Li, Z., Che, J., Wang, L., Li, X., Cao, Z., Zhang, J., Jin, L., et al. (2015) · BioMed Research International · doi:10.1155/2015/752930 · Cited by 159
Goodridge, L. D. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725348 · Cited by 155
Predicting In Vivo Efficacy of Therapeutic Bacteriophages Used To Treat Pulmonary Infections
Henry, M., Lavigne, R., & Debarbieux, L. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01596-13 · Cited by 148
Self-citationBoulanger, P. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-565-1_13 · Cited by 137
Phage therapy: awakening a sleeping giant
Roach, D. R., & Debarbieux, L. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170002 · Cited by 128
Self-citationGuidelines to Compose an Ideal Bacteriophage Cocktail
Merabishvili, M., Pirnay, J., & Vos, D. D. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7395-8_9 · Cited by 117
Pseudomonas aeruginosa Keratitis in Mice: Effects of Topical Bacteriophage KPP12 Administration
Fukuda, K., Ishida, W., Uchiyama, J., Rashel, M., Kato, S.-I., Morita, T., Muraoka, A., Sumi, T., Matsuzaki, S., Daibata, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047742 · Cited by 116
T4 phages against Escherichia coli diarrhea: Potential and problems
Denou, E., Bruttin, A., Barretto, C., Ngom‐Bru, C., Brüssow, H., & Zuber, S. (2009) · Virology · doi:10.1016/j.virol.2009.03.009 · Cited by 112
Betts, A., Vasse, M., Kaltz, O., & Hochberg, M. (2013) · Evolutionary Applications · doi:10.1111/eva.12085 · Cited by 102
Antibiotic Resistance of Bacteria
Chattopadhyay, M. K., Chakraborty, R., Grossart, H., Reddy, G. S. N., & Jagannadham, M. V. (2015) · BioMed Research International · doi:10.1155/2015/501658 · Cited by 79
Dufour, N., Clermont, O., Combe, B. L., Messika, J., Dion, S., Khanna, V., Denamur, É., Ricard, J.-D., & Debarbieux, L. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw253 · Cited by 77
Self-citationLacqua, A., Wanner, O., Colangelo, T., Martinotti, M. G., & Landini, P. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.1.956-959.2006 · Cited by 76
Dufour, N., Debarbieux, L., Fromentin, M., & Ricard, J.-D. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000000968 · Cited by 75
Self-citationOlszak, T., Żarnowiec, P., Kaca, W., Danis-Wlodarczyk, K. M., Augustyniak, D., Dřevínek, P., Soyza, A. D., McClean, S., & Drulis‐Kawa, Z. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6492-6 · Cited by 63
Wang, Y., Mi, Z., Niu, W., An, X., Yuan, X., Liu, H., Li, P., Liu, Y., Feng, Y., Huang, Y., et al. (2016) · Future Microbiology · doi:10.2217/fmb.16.11 · Cited by 59
dUTPase: the frequently overlooked enzyme encoded by many retroviruses
Hizi, A., & Herzig, E. (2015) · Retrovirology · doi:10.1186/s12977-015-0198-9 · Cited by 57
Genetic analysis of the immunity region of phage‐plasmid P4
Ghisotti, D., Chiaramonte, R., Forti, F., Zangrossi, S., Sironi, G., & Dehò, G. (1992) · Molecular Microbiology · doi:10.1111/j.1365-2958.1992.tb02208.x · Cited by 51
Self-citation
Cited by
Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01056-1 · Cited by 1,703
Horcajada, J. P., Montero, M., Oliver, A., Sorlí, L., Luque, S., Gómez-Zorrilla, S., Benito, N., & Grau, S. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00031-19 · Cited by 961
Pathogenesis of the Pseudomonas aeruginosa Biofilm: A Review
Tuon, F. F., Dantas, L. R., Suss, P. H., & Tasca Ribeiro, V. S. (2022) · Pathogens · doi:10.3390/pathogens11030300 · Cited by 422
Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles
Furfaro, L. L., Payne, M. S., & Chang, B. J. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00376 · Cited by 362
Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review
Chegini, Z., Khoshbayan, A., Taati Moghadam, M., Farahani, I., Jazireian, P., & Shariati, A. (2020) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-020-00389-5 · Cited by 321
Metadata
- Authors
- Forti, F., Roach, D. R., Cafora, M., Pasini, M. E., Horner, D. S., Fiscarelli, E. V., Rossitto, M., Cariani, L., Briani, F., Debarbieux, L., & Ghisotti, D.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2018-06
- Volume
- 62
- Issue
- 6
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2793753655
- Cited by
- 269
- References
- 46
- FWCI
- 20.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.